[Federal Register Volume 86, Number 8 (Wednesday, January 13, 2021)]
[Notices]
[Page 2686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; A Solicitation of the National 
Institutes of Health (NIH) and the Centers for Disease Control and 
Prevention (CDC) for Small Business Innovation Research (SBIR) 
Contract Proposals (N01), Topic 88 Phase II.
    Date: January 21, 2021.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G21A, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific 
Review Officer, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 5601 
Fishers Lane, Room 3G21A, Rockville, MD 20892, 301-761-7176, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2021-1: 
Therapeutic Targeting of Intracellular HIV-1 Proteins or Nucleic 
Acids (Topic 88).
    Date: January 21, 2021.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G21A, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific 
Review Officer, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 5601 
Fishers Lane, Room 3G21A, Rockville, MD 20892, 301-761-7176, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; A Solicitation of the National 
Institutes of Health (NIH) and the Centers for Disease Control and 
Prevention (CDC) for Small Business Innovation Research (SBIR) 
Contract Proposals (N01), Topic 89.
    Date: January 22, 2021.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G21A, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific 
Review Officer, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 5601 
Fishers Lane, Room 3G21A, Rockville, MD 20892, 301-761-7176, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2021-1: 
Particle-based Co-delivery of HIV immunogens as Next-generation HIV 
Vaccines (Topic 89).
    Date: January 22, 2021.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G21A, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific 
Review Officer, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 5601 
Fishers Lane, Room 3G21A, Rockville, MD 20892, 301-761-7176, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-00545 Filed 1-12-21; 8:45 am]
BILLING CODE 4140-01-P